Authors:
IRVIN WP
PRICE FV
BAILEY H
GELDER M
ROSENBLUTH R
DURIVAGE HJ
POTKUL RK
Citation: Wp. Irvin et al., A PHASE-II STUDY OF IRINOTECAN (CPT-11) IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX, Cancer, 82(2), 1998, pp. 328-333
Authors:
SCHULTZ MZ
SANDLER AB
DURIVAGE HJ
COOPER DL
Citation: Mz. Schultz et al., A PHASE-I PILOT-STUDY OF BCNU PLUS THYMIDINE IN PATIENTS WITH REFRACTORY CANCER, Cancer investigation, 14(3), 1996, pp. 218-224
Authors:
MURREN JR
DURIVAGE HJ
BUZAID AC
REISS M
FLYNN SD
CARTER D
HAIT WN
Citation: Jr. Murren et al., TRIFLUOPERAZINE AS A MODULATOR OF MULTIDRUG-RESISTANCE IN REFRACTORY BREAST-CANCER, Cancer chemotherapy and pharmacology, 38(1), 1996, pp. 65-70
Authors:
MURREN JR
DURIVAGE HJ
ROSENBERG AH
CHEN YT
DELPRETE SA
MURPHY GJ
BUZAID AC
HAIT WN
Citation: Jr. Murren et al., CISPLATIN, DOXORUBICIN, MITOMYCIN-C, AND 5-FLUOROURACIL FOR THE TREATMENT OF METASTATIC NONSMALL CELL LUNG-CANCER - LIMITED ACTIVITY OF AN AGGRESSIVE CHEMOTHERAPY REGIMEN, American journal of clinical oncology, 17(3), 1994, pp. 239-241
Authors:
MARSH JC
DURIVAGE HJ
DAVIS C
OHOLLAREN K
PASQUALE DN
SIMONICH SA
VOYNICK IM
BERTINO JR
Citation: Jc. Marsh et al., PHASE-II STUDY OF PULSE 5-FLUORO-2'-DEOXYURIDINE AND LEUCOVORIN IN ADVANCED COLORECTAL-CANCER PATIENTS PREVIOUSLY TREATED WITH CHEMOTHERAPY, American journal of clinical oncology, 15(2), 1992, pp. 115-118